Age-related macular degeneration (AMD) is a leading cause of blindness in elderly population.
It destroys sharp, central vision, which is needed for seeing objects clearly and for common daily tasks such as reading and driving. AMD may be detected with a combination of tests such as visual acuity test, dilated eye exam, tonometry, Amsler grid and fluorescein angiogram. This condition is not curable.
However, the progress of the disease to an advanced stage can be prevented. Current treatment options include laser photocoagulation, photodynamic therapy and anti- Vascular Endothelial Growth Factor (VEGF) therapy. There is a need to develop innovative drug delivery strategies to administer drugs effectively to the posterior segment of the eye. This article reviews the brief patho physiology, ongoing research, and recent combination drug therapies indicated in the treatment of AMD